Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Corcept Therapeutics Inc (NASDAQ:CORT)

5.45
Delayed Data
As of 3:59pm ET
 -0.05 / -0.91%
Today’s Change
3.22
Today|||52-Week Range
6.33
+9.44%
Year-to-Date
Mallinckrodt to Divest Nuclear Imaging Business for $690M
9:07am / Zacks.com - Paid Partner Content
Roche Launches Accu-Chek Blood Glucose Monitoring System
Aug 23 / Zacks.com - Paid Partner Content
Cempra's Application for Pneumonia Drug Validated in EU
Aug 24 / Zacks.com - Paid Partner Content
Supernus' Trokendi XR Gets FDA Nod for Migraine in Adults
Aug 22 / Zacks.com - Paid Partner Content
J&J (JNJ) Seeks EU Approval for Darzalex's Expanded Use
Aug 24 / Zacks.com - Paid Partner Content
What Falling Estimates & Price Mean for Merus Labs International (MSLI)
Aug 22 / Zacks.com - Paid Partner Content
Novartis Licenses Anti-PCSK9 Antibody to Cyon Therapeutics
Aug 24 / Zacks.com - Paid Partner Content
Insys Therapeutics Starts Enrollment in Cannabidiol Trial
Aug 19 / Zacks.com - Paid Partner Content
Gilead (GILD) Truvada Gets EU Approval for Label Expansion
Aug 23 / Zacks.com - Paid Partner Content
Valeant Stock Down on Lawsuit by T. Rowe, Alters Credit Loan
Aug 19 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close5.50
Today’s open5.52
Day’s range5.41 - 5.65
Volume132,895
Average volume (3 months)335,608
Market cap$608.3M
Dividend yield--
Data as of 3:59pm ET, 08/25/2016

Growth & Valuation

Earnings growth (last year)+80.65%
Earnings growth (this year)+129.17%
Earnings growth (next 5 years)+49.29%
Revenue growth (last year)+89.39%
P/E ratio545.0
Price/Sales10.59
Price/Book32.60

Competitors

 Today’s
change
Today’s
% change
DVAXDynavax Technologies...+0.06+0.37%
RPTPRaptor Pharmaceutica...+0.05+0.72%
AIMTAimmune Therapeutics...-0.27-1.82%
MACKMerrimack Pharmaceut...-0.10-2.05%
Data as of 3:59pm ET, 08/25/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)$0.01
Annual revenue (last year)$50.3M
Annual profit (last year)-$6.4M
Net profit margin-12.74%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer, Director &
MD
Joseph K. Belanoff
Secretary &
Chief Financial Officer
Gary Charles Robb
Corporate headquarters
Menlo Park, California

Forecasts

Partner Offers

Search for Jobs